Signature of lymphoid commitment at the expense of myeloid potency was ascertained by the expression trends of IL7R (common lymphoid marker) and CEBPA (myeloid marker) along with CDH2 and NT5E in individual ETP-ALL subjects (Figure 6D). This evidence concerns the gene CDH2 and acute lymphoblastic leukemia.